A regional citrate anticoagulation protocol for pre-dilutional CVVHDf: The 'Modified Alabama Protocol'

Australian Critical Care

Volumn 21, Issue 3, 2008, Pages 154-166

  Davies, Hugh ^a   Morgan, David ^a   Leslie, Gavin ^b  

^a ROYAL PERTH HOSPITAL   (Australia)

^b CURTIN UNIVERSITY   (Australia)

Author keywords

Continuous veno venous haemodiafiltration; Modified Alabama Protocol; Regional citrate anticoagulation

Indexed keywords

ANTICOAGULANT AGENT; CITRIC ACID;

ARTICLE; AUSTRALIA; CLINICAL PROTOCOL; DRUG MONITORING; HEMODIAFILTRATION; HUMAN; INSTRUMENTATION; MEDICAL RECORD; METHODOLOGY; NURSING;

ANTICOAGULANTS; AUSTRALIA; CITRIC ACID; CLINICAL PROTOCOLS; DRUG MONITORING; HEMODIAFILTRATION; HUMANS; NURSING RECORDS;

EID: 48349096735     PISSN: 10367314     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aucc.2008.04.002     Document Type: Article

References (28)

1. Dirkes S.M., and Hodge K. Continuous renal replacement therapy in the adult intensive care unit: history and current trends. Crit Care Nurse 27 2 (2007) 61-80
2. Uchino S., Fealy N., Baldwin I., Morimatsu H., and Bellomo R. Continuous is not continuous: the incidence and impact of circuit down-time on ureamic control during continuous veno-venous haemofiltration. Intensive Care Med 29 (2003) 575-578
3. Silvester W., Bellomo R., and Cole L. Epidemiology, management and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med 29 (2001) 1910-1915
4. Davies H., and Leslie G.D. Anticoagulation in CRRT: agents and strategies in Australian ICUs. Aust Crit Care 20 1 (2007) 15-26
5. Naka T., Egi M., Bellomo R., Cole L., French C., Botha J., et al. Commercial low-citrate anticoagulation haemofiltration in high risk patients with frequent filter clotting. Anaesth Intensive Care 33 5 (2005) 601-608
6. Cointault O., Kamar N., Bories P., Lavayssiere L., Angles O., Rostaing L., et al. Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions. Nephrol Dial Transplant 19 (2004) 171-178
7. Mitchell A., Daul A.E., Beiderlinden M., Schafers R.F., Heemann U., Kribben A., et al. A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD). Clin Nephrol 59 2 (2003) 106-114
8. Munjal S., and Ejaz A.A. Regional citrate anticoagulation in continuous venovenous haemofiltration using commercial preparations. Nephrology 11 (2006) 405-409
9. Tolwani A.J., Prendergast M.B., Speer R.R., Stofan B.S., and Wille K.M. A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance. Clin J Am Soc Nephrol 1 1 (2006) 79-87
10. Saudan P., Niederberger M., de Seigneux S., Romand J., Pugin J., Perneger T., et al. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int 70 7 (2006) 1312-1317
11. Moran T.A., and Viele C.S. Normal clotting. Semin Oncol Nurs 21 4 (2005) 1-11
12. Uchino S., Bellomo R., Morimatsu H., Morgera S., Schetz M., Tan I., et al. Continuous renal replacement therapy: a worldwide practice survey. The Beginning and Ending Supportive Therapy for the Kidney (B. E. S. T. Kidney) investigators. Intensive Care Med 33 (2007) 1563-1570
13. Morabito S., Guzzo I., Solazzo A., Muzi L., Luciani R., and Pierucci A. Continous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding. J. Nephrol 16 (2003) 566-571
14. Abramson S., and Niles J.L. Anticoagulation in continuous renal replacement therapy. Curr Opin Nephrol Hypertens 8 (1999) 701-707
15. Balik M., Waldauf P., Plasil P., and Pachl J. Prostacyclin versus citrate in continuous haemodiafiltration: an observational study in patients with high risk of bleeding. Blood Purif 23 (2005) 325-329
16. Langenecker S.A., Felfernig M., Werba A., Mueller C.M., Chiari A., and Zimpfer M. Anticoagulation with prostacyclin and heparin during continuous venovenous hemofiltration. Crit Care Med 22 11 (1994) 1774-1781
17. Davenport A. Anticoagulation for continuous renal replacement therapy. Contrib Nephrol 144 (2004) 228-238
18. Uchino S., Fealy N., Baldwin I., Morimatsu H., and Bellomo R. Continuous venovenous hemofiltration without anticoagulation. Am Soc Artif Intern Organs J 50 (2004) 76-80
19. Kutsogiannis D.J., Gibney R.T., Stollery D., and Gao J. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int 67 (2005) 2361-2367
20. Fealy N., Baldwin I., Johnstone M., Egi M., and Bellomo R. A pilot randomized controlled crossover study comparing regional heparinization to regional citrate anticoagulation for continuous venovenous hemofiltration. Int J Artif Organs 30 4 (2007) 301-307
21. Kutsogiannis D.J., Mayers I., Chin W.D., and Gibney R.T. Regional citrate anticoagulation in continuous veno-venous hemodiafiltration. Am J Kidney Dis 35 5 (2000) 802-811
22. Gabutti L., Marone C., Colucci G., Duchini F., and Schonholzer C. Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge. Intensive Care Med 28 (2002) 1419-1425
23. Dorval M., Madore F., Courteau S., and Leblanc M. A novel citrate anticoagulation regimen for continuous venovenous hemodiafiltration. Intensive Care Med 29 (2003) 1186-1189
24. Schiffl H., Lang S.M., and Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 346 5 (2002) 305-310
25. Ronco C., Bellomo R., Homel P., Brendolan A., Maurizio D., Piccinni P., et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356 (2000) 26-30
26. http://www.ismp.org/Newsletters/acutecare/articles/19970507.asp (6 April 2008).
27. Andrews T., Waterman H., and Hillier V. Blood gas analysis: a study of blood loss in intensive care. J Adv Nurs 30 4 (1999) 851-857
28. Morgera S., Scholle C., Melzer C., Slowinski T., Liefeld L., Baumann G., et al. A simple, safe and effective citrate anticoagulation protocol for the Genius Dialysis System in acute renal failure. Nephron Clin Pract 98 (2004) c35-c40